In addition, Mohammed et al. (16) reported that lack of TMEM158 decreased the resistance to cisplatin in non-small cell lung cancer (NSCLC) cell and that TMEM158 could serve as a biomarker of cisplatin sensitivity in NSCLC. This evidence concerns the gene TMEM158 and non-small cell lung carcinoma.